Showing results (1-10 of 36) with videos related to
Sort By:
Pageof 4
Science Progress|December 12, 2024
Assessment of technology adoption in construction safety management: Case study in ChinaJinjing Xu, Jintao Li, Xiaohong ChenJournal of Cancer Research and Clinical Oncology|October 31, 2022
The dual role and mutual dependence of heme/HO-1/Bach1 axis in the carcinogenic and anti-carcinogenic intersectionJinjing Xu, Kuiyang Zhu, Yali Wang, et al.Frontiers in Oncology|October 31, 2022
Role of STAT3 in the pathogenesis of nasopharyngeal carcinoma and its significance in anticancer therapyYishimei Si, Jinjing Xu, Linghan Meng, et al.The Science of the Total Environment|January 25, 2020
Environmental efficiency evaluation of China's iron and steel industry: A process-level data envelopment analysisYihan Wang, Zongguo Wen, Xin Cao, et al.Oncology Letters|July 17, 2018
Combination therapy: A feasibility strategy for CAR-T cell therapy in the treatment of solid tumorsJinjing Xu, Yali Wang, Jing Shi, et al.Molecular Medicine Reports|December 6, 2017
Current status and future prospects of the strategy of combining CAR‑T with PD‑1 blockade for antitumor therapy (Review)Jinjing Xu, Qing Zhang, Kang Tian, et al.Human Mutation|October 3, 2025
The Role of NOL3 in Colon Adenocarcinoma Metastasis and Its Association With DNA MethylationLi Hong, Hao Zhang, Ruipeng Wang, et al.International Journal of Computer Assisted Radiology and Surgery|December 22, 2025
DyEndoVO: scene dynamics-aware pose estimation of endoscope in minimally invasive surgeryJinjing Xu, Reuben Docea, Micha Pfeiffer, et al.Frontiers in Immunology|May 2, 2025
The malignant signature gene of cancer-associated fibroblasts serves as a potential prognostic biomarker for colon adenocarcinoma patientsHao Zhang, Zirui Zhuang, Li Hong, et al.Molecular Medicine Reports|March 31, 2017
iRGD as a tumor‑penetrating peptide for cancer therapy (Review)Hong Yin, Jie Yang, Qing Zhang, et al.Pageof 4